$2.16
-0.17-7.30%
At Close: -
$2.16
00.00%
After Hours: 7:11 PM EDT
15 minutes delayed
Allogene Therapeutics
ALLONASDAQ
Allogene Therapeutics (NASDAQ:ALLO) Stock, Earnings Estimates, EPS, And Revenue
Allogene Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Jul 31
EPS Estimate
$-0.390
Quarterly Revenue Estimate
$10K
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$87K
Analyze the earnings history of Allogene Therapeutics using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ALLO | Allogene Therapeutics | -$0.53 | -$0.39 | — | — | $44.00K | $10.00K | — | — | 07/31/2024 | Get Alert |
| ALLO | Allogene Therapeutics | -$0.68 | -$0.41 | -$0.38 | 7.32% | $30.00K | $10.00K | $22.00K | 120.00% | 05/13/2024 | Get Alert |
| ALLO | Allogene Therapeutics | -$0.67 | -$0.45 | -$0.43 | 4.44% | $26.00K | $20.00K | $21.00K | 5.00% | 03/14/2024 | Get Alert |
| ALLO | Allogene Therapeutics | -$0.58 | -$0.52 | -$0.37 | 28.85% | $49.00K | $10.00K | $43.00K | 330.00% | 11/02/2023 | Get Alert |
| ALLO | Allogene Therapeutics | -$0.52 | -$0.59 | -$0.53 | 10.17% | $86.00K | $70.00K | $44.00K | -37.14% | 08/02/2023 | Get Alert |
| ALLO | Allogene Therapeutics | -$0.56 | -$0.62 | -$0.68 | -9.68% | $61.00K | $10.00K | $52.00K | 420.00% | 05/03/2023 | Get Alert |
| ALLO | Allogene Therapeutics | -$0.54 | -$0.70 | -$0.66 | 5.71% | $51.00K | $60.00K | $47.00K | -21.67% | 02/28/2023 | Get Alert |
| ALLO | Allogene Therapeutics | -$0.57 | -$0.64 | -$0.58 | 9.38% | $49.00K | $10.00K | $49.00K | 390.00% | 11/02/2022 | Get Alert |
| ALLO | Allogene Therapeutics | -$0.53 | -$0.61 | -$0.52 | 14.75% | $44.00K | $10.00K | $86.00K | 760.00% | 08/09/2022 | Get Alert |
| ALLO | Allogene Therapeutics | -$0.25 | -$0.58 | -$0.56 | 3.45% | $38.34M | — | $61.00K | — | 05/04/2022 | Get Alert |
| ALLO | Allogene Therapeutics | -$0.53 | -$0.60 | -$0.54 | 10.00% | $0.00 | -$10.00K | $51.00K | 610.00% | 02/23/2022 | Get Alert |
| ALLO | Allogene Therapeutics | -$0.52 | -$0.56 | -$0.57 | -1.79% | $0.00 | $10.00K | $49.00K | 390.00% | 11/04/2021 | Get Alert |
| ALLO | Allogene Therapeutics | -$0.53 | -$0.55 | -$0.53 | 3.64% | $0.00 | — | $44.00K | — | 08/04/2021 | Get Alert |
| ALLO | Allogene Therapeutics | -$0.50 | -$0.46 | -$0.25 | 45.65% | $0.00 | $13.92M | $38.34M | 175.47% | 05/05/2021 | Get Alert |
| ALLO | Allogene Therapeutics | -$0.58 | -$0.56 | -$0.53 | 5.36% | $0.00 | $3.17M | $0.00 | -100.00% | 02/25/2021 | Get Alert |
| ALLO | Allogene Therapeutics | -$0.50 | -$0.54 | -$0.52 | 3.70% | $0.00 | — | $0.00 | — | 11/04/2020 | Get Alert |
| ALLO | Allogene Therapeutics | -$0.41 | -$0.54 | -$0.53 | 1.85% | $0.00 | — | $0.00 | — | 08/05/2020 | Get Alert |
| ALLO | Allogene Therapeutics | -$0.32 | -$0.58 | -$0.50 | 13.79% | $0.00 | — | $0.00 | — | 05/06/2020 | Get Alert |
| ALLO | Allogene Therapeutics | -$0.37 | -$0.68 | -$0.58 | 14.71% | $0.00 | — | $0.00 | — | 02/27/2020 | Get Alert |
| ALLO | Allogene Therapeutics | -$10.71 | — | -$0.50 | — | $0.00 | — | $0.00 | — | 11/05/2019 | Get Alert |
| ALLO | Allogene Therapeutics | — | -$0.46 | -$0.41 | 10.87% | — | — | $0.00 | — | 08/07/2019 | Get Alert |
Allogene Therapeutics (ALLO) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Mar 2024 | 2024-05-13 | $-0.38 | $-0.41 | 7.32 % |
| Dec 2023 | 2024-03-14 | $-0.43 | $-0.45 | 4.44 % |
| Sep 2023 | 2023-11-02 | $-0.37 | $-0.52 | 28.8 % |
| Jun 2023 | 2023-08-02 | $-0.53 | $-0.59 | 10.2 % |
Allogene Therapeutics (ALLO) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Mar 2024 | 2024-05-13 | $22.00K | $10.00K | 120.0 % |
| Dec 2023 | 2024-03-14 | $21.00K | $20.00K | 5.00 % |
| Sep 2023 | 2023-11-02 | $43.00K | $10.00K | 330.0 % |
| Jun 2023 | 2023-08-02 | $44.00K | $70.00K | -37.1 % |
FAQ
When is Allogene Therapeutics (NASDAQ:ALLO) reporting earnings?
Allogene Therapeutics (ALLO) is scheduled to report earnings on July 31, 2024. The last reported earnings were for reported on May 13, 2024 for Q1.
What were the latest earnings per share (EPS) for Allogene Therapeutics (NASDAQ:ALLO)?
The Actual EPS was $-0.38, which beat the estimate of $-0.41.
What were Allogene Therapeutics’s (NASDAQ:ALLO) revenues?
The Actual Revenue was $22K, which beat the estimate of $10K.
Browse earnings estimates, EPS, and revenue on all stocks.